Prior work suggests uptake of apoptotic cells may drive CCR7‐associated cDC1 activation programmes [15, 35], while IRF1 and NF‐κB pathways have been more generally linked to cDC1 activation in tumours [36]. This evidence concerns the gene NFKB1 and neoplasm.